Van't Hof RJ - Search Results

1

The type 2 cannabinoid receptor regulates bone mass and ovariectomy-induced bone loss by affecting osteoblast differentiation and bone formation.

Sophocleous A, Landao-Bassonga E, Van't Hof RJ, Idris AI, Ralston SH. Sophocleous A, et al. Endocrinology. 2011 Jun;152(6):2141-9. doi: 10.1210/en.2010-0930. Epub 2011 Mar 29. Endocrinology. 2011. PMID: 21447627

2

Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro.

Idris AI, Rojas J, Greig IR, Van't Hof RJ, Ralston SH. Idris AI, et al. Calcif Tissue Int. 2008 Mar;82(3):191-201. doi: 10.1007/s00223-008-9104-y. Epub 2008 Feb 8. Calcif Tissue Int. 2008. PMID: 18259679

3

Identification of novel biphenyl carboxylic acid derivatives as novel antiresorptive agents that do not impair parathyroid hormone-induced bone formation.

Idris AI, Greig IR, Bassonga-Landao E, Ralston SH, van 't Hof RJ. Idris AI, et al. Endocrinology. 2009 Jan;150(1):5-13. doi: 10.1210/en.2008-0998. Epub 2008 Sep 4. Endocrinology. 2009. PMID: 18772231

4

The biphenyl-carboxylate derivative ABD328 is a novel orally active antiresorptive agent.

Idris AI, Coste E, Greig IR, Ralston SH, van't Hof RJ. Idris AI, et al. Calcif Tissue Int. 2010 Dec;87(6):525-32. doi: 10.1007/s00223-010-9417-5. Epub 2010 Sep 18. Calcif Tissue Int. 2010. PMID: 20852852

5

Regulation of bone mass and bone turnover by neuronal nitric oxide synthase.

van't Hof RJ, Macphee J, Libouban H, Helfrich MH, Ralston SH. van't Hof RJ, et al. Endocrinology. 2004 Nov;145(11):5068-74. doi: 10.1210/en.2004-0205. Epub 2004 Aug 5. Endocrinology. 2004. PMID: 15297441

6

Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors.

Idris AI, van 't Hof RJ, Greig IR, Ridge SA, Baker D, Ross RA, Ralston SH. Idris AI, et al. Nat Med. 2005 Jul;11(7):774-9. doi: 10.1038/nm1255. Epub 2005 May 22. Nat Med. 2005. PMID: 15908955 Free PMC article.

7

Regulation of bone mass, osteoclast function, and ovariectomy-induced bone loss by the type 2 cannabinoid receptor.

Idris AI, Sophocleous A, Landao-Bassonga E, van't Hof RJ, Ralston SH. Idris AI, et al. Endocrinology. 2008 Nov;149(11):5619-26. doi: 10.1210/en.2008-0150. Epub 2008 Jul 17. Endocrinology. 2008. PMID: 18635663

8

Cannabinoid receptor type 1 protects against age-related osteoporosis by regulating osteoblast and adipocyte differentiation in marrow stromal cells.

Idris AI, Sophocleous A, Landao-Bassonga E, Canals M, Milligan G, Baker D, van't Hof RJ, Ralston SH. Idris AI, et al. Cell Metab. 2009 Aug;10(2):139-47. doi: 10.1016/j.cmet.2009.07.006. Cell Metab. 2009. PMID: 19656492 Free article.

9

Development and characterization of biphenylsulfonamides as novel inhibitors of bone resorption.

Greig IR, Idris AI, Ralston SH, van't Hof RJ. Greig IR, et al. J Med Chem. 2006 Dec 14;49(25):7487-92. doi: 10.1021/jm051236m. J Med Chem. 2006. PMID: 17149877

10

The nitrosylated flurbiprofen derivative HCT1026 inhibits cytokine-induced signalling through a novel mechanism of action.

Idris AI, Ralston SH, van't Hof RJ. Idris AI, et al. Eur J Pharmacol. 2009 Jan 14;602(2-3):215-22. doi: 10.1016/j.ejphar.2008.11.023. Epub 2008 Nov 19. Eur J Pharmacol. 2009. PMID: 19046964

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Search Page

Filters